MTMR10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.628440E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.125400E-01
Normal-vs-Stage2
1.611660E-02
Normal-vs-Stage3
5.942100E-02
Normal-vs-Stage4
3.920200E-01
Stage1-vs-Stage2
1.493560E-01
Stage1-vs-Stage3
7.966500E-02
Stage1-vs-Stage4
9.942200E-01
Stage2-vs-Stage3
1.639040E-01
Stage2-vs-Stage4
2.255000E-01
Stage3-vs-Stage4
2.119600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.598450E-02
Normal-vs-AfricanAmerican
2.318800E-01
Normal-vs-Asian
2.186300E-02
Caucasian-vs-AfricanAmerican
5.158800E-01
Caucasian-vs-Asian
2.041800E-01
AfricanAmerican-vs-Asian
1.849220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.290470E-02
Normal-vs-Female
2.937500E-02
Male-vs-Female
2.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.886400E-01
Normal-vs-Age(41-60Yrs)
4.337700E-02
Normal-vs-Age(61-80Yrs)
1.310390E-02
Normal-vs-Age(81-100Yrs)
3.252100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.044400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.154600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.360180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.696830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.419240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.170800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.975000E-03
Normal-vs-Daily Drinker
1.054190E-02
Normal-vs-Weekly Drinker
1.224370E-01
Normal-vs-Occasional Drinker
5.701500E-02
Normal-vs-Social Drinker
1.173370E-01
Non Drinker-vs-Daily Drinker
8.250000E-01
Non Drinker-vs-Weekly Drinker
8.179000E-01
Non Drinker-vs-Occasional Drinker
4.117800E-01
Non Drinker-vs-Social Drinker
2.175800E-01
Daily Drinker-vs-Weekly Drinker
9.161200E-01
Daily Drinker-vs-Occasional Drinker
5.537400E-01
Daily Drinker-vs-Social Drinker
3.201000E-01
Weekly Drinker-vs-Occasional Drinker
7.691800E-01
Weekly Drinker-vs-Social Drinker
5.681000E-01
Occasional Drinker-vs-Social Drinker
6.977600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.637900E-02
Normal-vs-Grade 2
1.875360E-03
Normal-vs-Grade 3
1.681840E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.423000E-01
Grade 1-vs-Grade 3
7.260000E-01
Grade 1-vs-Grade 4
2.637900E-02
Grade 2-vs-Grade 3
9.350000E-01
Grade 2-vs-Grade 4
1.875360E-03
Grade 3-vs-Grade 4
1.681840E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.973500E-02
Normal-vs-NonDiabetic
9.902100E-03
Diabetic-vs-NonDiabetic
6.080000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.166800E-01
Normal-vs-NoPancreatitis
1.605880E-02
Pancreatitis-vs-NoPancreatitis
3.303600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.796500E-02
Normal-vs-N1
1.797770E-02
N0-vs-N1
6.762200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.959790E-01
Normal-vs-TP53-NonMutant
1.178420E-01
TP53-Mutant-vs-TP53-NonMutant
2.031500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
